Andrea Lobo,  —

Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.

Articles by Andrea Lobo

Largest Study on Parkinson’s Disease Genetics Reaches 12,500 Patients

CENTOGENE has announced it’s reached a milestone of 12,500 participants who have been recruited and genetically tested as part of the Rockstock International Parkinson’s Disease Study (ROPAD), a global observational effort to characterize the genetic profile of Parkinson’s patients. ROPAD (NCT03866603), developed in collaboration with Denali…

Older Age and Motor Symptom Severity Tied to Fall Risk After DBS

Older age at onset, more severe motor symptoms, and cognitive impairment are risk factors for the progression of gait and postural instability in Parkinson’s disease patients who undergo deep brain stimulation, a new study suggests. Researchers, who followed patients for up to 15 years after the surgery, found…

Free Art Classes for Patients, Caregivers Opening in Arkansas

Free art therapy workshops for Parkinson’s disease patients and their caregivers will take place this fall in Little Rock and Hot Springs, Arkansas, offered by the University of Arkansas for Medical Sciences (UAMS) Movement Disorders Clinic. The Art for Parkinson’s classes are scheduled in Little Rock at St. Michael’s…

Poor Sleep Raises Risk of Dyskinesia With Parkinson’s, Study Finds

Poor sleep quality is a key factor in developing dyskinesia, the uncontrolled and involuntary movements that can affect people with Parkinson’s disease, a study that followed patients for up to three years suggests. “[Poor sleep quality] may increase the risk of developing dyskinesia in PD [Parkinson’s disease], implying that therapeutic…

New Method Devised to Generate Dopaminergic Neurons

Researchers have devised a new method to generate dopamine-producing neurons from skin cells of Parkinson’s disease patients, a process that could be used to better study the molecular mechanisms of the disease and develop new treatments. The cells retained many relevant aspects of the disease, including the accumulation of…

Survival With Parkinson’s Tied to Age at Onset, Cognition in Study

Older age at onset, a faster rate of disease progression, and severe cognitive impairment are key factors in poorer survival rates for people with Parkinson’s disease, a study that followed patients in northern China for 10 years found. Fatigue may also be an indicator of poorer survival, while physical exercise…

At-home Gait Monitor May Track Progression, Treatment Response

Continuously monitoring the gait of Parkinson’s disease patients in their homes using a wireless device is feasible and may provide more sensitive measurements of disease progression and treatment response, according to a new study. The device, which monitors fluctuations in motor function by tracking gait speed, may improve disease…

MJFF and Edmond J. Safra Foundation Expand Network

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced it will expand the number and reach of Parkinson’s disease clinician-researchers around the world, in partnership with the Edmond J. Safra Foundation. The Edmond J. Safra Fellowship in Movement Disorders aims to fund medical centers to…

Raised Disease Risk Tied to Early, Midlife Hospital-treated Infections

A new study suggests that infections requiring specialty hospital care are associated with an increased risk of developing Parkinson’s disease later in life. An increased risk also was observed for Alzheimer’s disease, but not for amyotrophic lateral sclerosis (ALS). “Hospital-treated infections, especially in early- and mid-life, were associated with…